CoChat

Congenital Hypothyroidism: An Evolving Common Clinical Conundrum

Rapaport, Robert · 2010 · The Journal of Clinical Endocrinology & Metabolism
Cited by 30

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Newborn screening for congenital hypothyroidism, initiated in 1975 (1), has led to the recognition and treatment of affected infants before the onset of clinical signs and symptoms of hypothyroidism. Widespread screening has in large part reduced, if not eliminated, the adverse neurological and developmental effects of congenital hypothyroidism. Compared with the prescreening period, the worldwide reported incidence has more than doubled and is now estimated to be between 1:2000 and 1:4000 newborns. Although there is general agreement that treatment should begin as early as possible and with daily oral doses of T4 between 10 and 15 μg/kg (2), there is a remarkable lack of uniformity in the diagnoses assigned and in the reporting and follow-up of infants identified and treated with hormone replacement therapy. A report by Mengreli et al. in the current issue of JCEM (3) using a primary TSH screening method (at 3–5 d of age) reports a significant increase in the incidence of congenital hypothyroidism diagnosed when the neonatal TSH threshold limit was decreased from 20 to 10 mU/liter. With this change, 28% more infants were placed on replacement thyroid hormone (3). Not unexpectedly, this also resulted in a 10-fold rise in the recall rate of screened infants. At 3 yr of age, 151 of the 200 children identified as having congenital hypothyroidism were reevaluated. What was most remarkable is that 88.7% of the 151 reevaluated children were deemed to have permanent hypothyroidism. Thirty-one (20%) of the reevaluated children were premature infants, with 23 of these children having permanent hypothyroidism. One third of the babies with permanent hypothyroidism had screening TSH levels between 10 and 20 mU/liter and would therefore have been missed had the cutoff level remained at 20 mU/liter, and half of the premature babies with persistent congenital hypothyroidism had screening TSH levels of less than 20 mU/liter. Structural abnormalities of the thyroid gland were detected in 20% of the infants with screening TSH levels of less than 20 mU/liter. The diagnosis of permanent hypothyroidism was based on a serum TSH concentration of greater than the upper limit of normal for the assay (5 mU/liter) after discontinuation of therapy for at least 3 wk, the presence of a sibling with an increased serum TSH, or an abnormal thyroid gland on either imaging or functional tests. Imaging tests consisted of ultrasound and radioisotope screening and perchlorate discharge. Of note, the initial screening was obtained at 3–5 d of age, which is somewhat later than the age at which screening tests are obtained in the United States. By applying the TSH threshold of 10 mU/liter, the prevalence of permanent congenital hypothyroidism was 1:1,749, whereas that of transient congenital hypothyroidism was 1:14,154. These findings are consistent with those of Corbetta et al. (4), who reported an increase in the incidence of congenital hypothyroidism from 1:2654 to 1:1446 cases with a reduction in TSH cutoff from greater than 20 mU/liter to greater than 10–12 mU/liter. The increase was largely, but not exclusively, in those with eutopic thyroid glands. When reevaluated at 3 yr of age, 78% of these cases were thought to have permanent hypothyroidism. TSH levels greater than 10 mU/liter with low or normal free T4 were seen in 34% of the cases, and mild permanent thyroid dysfunction with TSH levels between 5 and 9.9 mU/liter with normal free T4 was seen in 44% of the cases. In the United Kingdom, the initial screening threshold adopted by the various neonatal screening services ranged from 5–12 mU/liter in samples collected between 5 and 8 d of life. All programs use similar laboratory technology to assay TSH. Korada et al. (5) suggested that a cutoff value of 10 mU/liter compared with 6 mU/liter may miss several babies with congenital hypothyroidism, although the number of false-positive term infants increased by 126%. In the United States, there has been a similar increase in the reported incidence (birth prevalence) of congenital hypothyroidism, without alteration in screening threshold levels. In New York State alone, using a primary T4 screen, the incidence of congenital hypothyroidism between 1978 and 2005 increased by 138% to approximately 1:1400. This figure is remarkably similar to that reported by Mengreli et al. (3) and Corbetta et al. (4) with the lower TSH cutoff levels. In the United States, with 58 million infants screened between 1987 and 2002, the incidence increased by 73% (6). Reports were recently published from a workshop held in 2008 at the Centers for Disease Control in Atlanta, Georgia, designed to explore the causes of the apparent increase in the prevalence of congenital hypothyroidism. Modifications and improvements in laboratory practices, population shifts, and the reporting of patients with transient hypothyroidism among those with congenital hypothyroidism were all thought to be insufficient explanations of the remar

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2010-1711

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 30

Metadata

Authors
Rapaport, R.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2010-09
Volume
95
Issue
9
Pages
4223-4225
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2048122301
Cited by
30
References
1
FWCI
2.20
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Congenital Hypothyroidism: An Evolving Common Clinical Conundrum. https://app.cochat.ai/papers/10.1210/jc.2010-1711
The paper
Rapaport, R. (2010). Congenital Hypothyroidism: An Evolving Common Clinical Conundrum. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2010-1711

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.